The arrival of Pfizer's antiviral tablet is expected in Cyprus in mid-February, Dr.Elena Panagiotopoulou, Deputy Director of Pharmaceutical Services of the Ministry of Health, told CNA.She said that this particular pill, called Paxlovid, will cover the treatment of more than 15 thousand patients.
According to Dr Panagiotopoulou, this is the second antiviral pill to be received by Cyprus, which, according to the manufacturer, is up to 90% effective in preventing hospitalizations and deaths from coronavirus for patients belonging to high-risk groups.
It should be noted that according to the latest laboratory data, the drug also retains its efficacy against the Omicron mutation.
As Dr. Panagiotopoulou, Paxlovid was one of the two drugs tested
(CNA)
CNA - Emili Lambrou
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
